Robert M Dewitty
Examiner (ID: 7428)
Most Active Art Unit | 1616 |
Art Unit(s) | 1616, 2857 |
Total Applications | 114 |
Issued Applications | 57 |
Pending Applications | 4 |
Abandoned Applications | 53 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 1553873
[patent_doc_number] => 06348469
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-19
[patent_title] => 'Solid compositions containing glipizide and polyethylene oxide'
[patent_app_type] => B1
[patent_app_number] => 09/579392
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5589
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/348/06348469.pdf
[firstpage_image] =>[orig_patent_app_number] => 09579392
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/579392 | Solid compositions containing glipizide and polyethylene oxide | May 25, 2000 | Issued |
Array
(
[id] => 1551006
[patent_doc_number] => 06399609
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-04
[patent_title] => 'Therapeutic usage of tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders'
[patent_app_type] => B1
[patent_app_number] => 09/570775
[patent_app_country] => US
[patent_app_date] => 2000-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29243
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/399/06399609.pdf
[firstpage_image] =>[orig_patent_app_number] => 09570775
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/570775 | Therapeutic usage of tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders | May 10, 2000 | Issued |
Array
(
[id] => 1450613
[patent_doc_number] => 06455541
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Suppression, by 5-lipoxygenase inhibitors, of bone resorption'
[patent_app_type] => B1
[patent_app_number] => 09/567308
[patent_app_country] => US
[patent_app_date] => 2000-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 36
[patent_no_of_words] => 8836
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455541.pdf
[firstpage_image] =>[orig_patent_app_number] => 09567308
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/567308 | Suppression, by 5-lipoxygenase inhibitors, of bone resorption | May 7, 2000 | Issued |
Array
(
[id] => 1478023
[patent_doc_number] => 06344464
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-05
[patent_title] => 'Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination'
[patent_app_type] => B1
[patent_app_number] => 09/403507
[patent_app_country] => US
[patent_app_date] => 2000-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10090
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 439
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/344/06344464.pdf
[firstpage_image] =>[orig_patent_app_number] => 09403507
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403507 | Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination | Apr 17, 2000 | Issued |
Array
(
[id] => 1586378
[patent_doc_number] => 06358990
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Method for treating Alzheimer\'s disease'
[patent_app_type] => B1
[patent_app_number] => 09/529526
[patent_app_country] => US
[patent_app_date] => 2000-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3543
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358990.pdf
[firstpage_image] =>[orig_patent_app_number] => 09529526
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/529526 | Method for treating Alzheimer's disease | Apr 12, 2000 | Issued |
Array
(
[id] => 1560415
[patent_doc_number] => 06436983
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Treatment for alzheimer\'s disease'
[patent_app_type] => B1
[patent_app_number] => 09/529247
[patent_app_country] => US
[patent_app_date] => 2000-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6488
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436983.pdf
[firstpage_image] =>[orig_patent_app_number] => 09529247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/529247 | Treatment for alzheimer's disease | Apr 9, 2000 | Issued |
Array
(
[id] => 1420760
[patent_doc_number] => 06515018
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Synergistic compositions for lycopene and Vitamin E for the prevention of LDL oxidation'
[patent_app_type] => B1
[patent_app_number] => 09/446241
[patent_app_country] => US
[patent_app_date] => 2000-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 3137
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/515/06515018.pdf
[firstpage_image] =>[orig_patent_app_number] => 09446241
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446241 | Synergistic compositions for lycopene and Vitamin E for the prevention of LDL oxidation | Apr 2, 2000 | Issued |
Array
(
[id] => 1478821
[patent_doc_number] => 06451834
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Indeno1,2-c-, naphtho1,2-c- and benzo6,7cyclohepta1,2-cpyrazole derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/541222
[patent_app_country] => US
[patent_app_date] => 2000-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12517
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451834.pdf
[firstpage_image] =>[orig_patent_app_number] => 09541222
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/541222 | Indeno1,2-c-, naphtho1,2-c- and benzo6,7cyclohepta1,2-cpyrazole derivatives | Apr 2, 2000 | Issued |
Array
(
[id] => 7645536
[patent_doc_number] => 06472434
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Method for minimizing excess collagen deposition'
[patent_app_type] => B1
[patent_app_number] => 09/539737
[patent_app_country] => US
[patent_app_date] => 2000-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9318
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472434.pdf
[firstpage_image] =>[orig_patent_app_number] => 09539737
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/539737 | Method for minimizing excess collagen deposition | Mar 29, 2000 | Issued |
Array
(
[id] => 4268880
[patent_doc_number] => 06306841
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Treatment of female sexual dysfunction'
[patent_app_type] => 1
[patent_app_number] => 9/539484
[patent_app_country] => US
[patent_app_date] => 2000-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9372
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/306/06306841.pdf
[firstpage_image] =>[orig_patent_app_number] => 539484
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/539484 | Treatment of female sexual dysfunction | Mar 29, 2000 | Issued |
Array
(
[id] => 1416469
[patent_doc_number] => 06521624
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities'
[patent_app_type] => B1
[patent_app_number] => 09/535042
[patent_app_country] => US
[patent_app_date] => 2000-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 31
[patent_no_of_words] => 65228
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521624.pdf
[firstpage_image] =>[orig_patent_app_number] => 09535042
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/535042 | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities | Mar 22, 2000 | Issued |
Array
(
[id] => 7640188
[patent_doc_number] => 06395727
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-28
[patent_title] => 'Method of treating Bulimia Nervosa and related eating disorders by administration of atypical antipsychotic medications'
[patent_app_type] => B1
[patent_app_number] => 09/531129
[patent_app_country] => US
[patent_app_date] => 2000-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3200
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/395/06395727.pdf
[firstpage_image] =>[orig_patent_app_number] => 09531129
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/531129 | Method of treating Bulimia Nervosa and related eating disorders by administration of atypical antipsychotic medications | Mar 16, 2000 | Issued |
Array
(
[id] => 1528367
[patent_doc_number] => 06479494
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Arylalkanoyl pyridazines'
[patent_app_type] => B1
[patent_app_number] => 09/525455
[patent_app_country] => US
[patent_app_date] => 2000-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7091
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09525455
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/525455 | Arylalkanoyl pyridazines | Mar 14, 2000 | Issued |
Array
(
[id] => 1414156
[patent_doc_number] => 06525037
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Method of treating atherosclerosis and complications resulting therefrom'
[patent_app_type] => B1
[patent_app_number] => 09/513540
[patent_app_country] => US
[patent_app_date] => 2000-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2063
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525037.pdf
[firstpage_image] =>[orig_patent_app_number] => 09513540
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/513540 | Method of treating atherosclerosis and complications resulting therefrom | Feb 24, 2000 | Issued |
Array
(
[id] => 1279099
[patent_doc_number] => 06646008
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-11
[patent_title] => 'Treatment of disease states which result from neoplastic cell proliferation using PPAR- activators and compositions useful therefor'
[patent_app_type] => B1
[patent_app_number] => 09/331535
[patent_app_country] => US
[patent_app_date] => 2000-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9577
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/646/06646008.pdf
[firstpage_image] =>[orig_patent_app_number] => 09331535
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/331535 | Treatment of disease states which result from neoplastic cell proliferation using PPAR- activators and compositions useful therefor | Feb 21, 2000 | Issued |
Array
(
[id] => 4289098
[patent_doc_number] => 06211229
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Treatment of transient and short term insomnia'
[patent_app_type] => 1
[patent_app_number] => 9/506348
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3644
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211229.pdf
[firstpage_image] =>[orig_patent_app_number] => 506348
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506348 | Treatment of transient and short term insomnia | Feb 16, 2000 | Issued |
Array
(
[id] => 1166345
[patent_doc_number] => 06756365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-29
[patent_title] => 'Reducing tetracycline resistance in living cells'
[patent_app_type] => B2
[patent_app_number] => 09/504697
[patent_app_country] => US
[patent_app_date] => 2000-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 33
[patent_no_of_words] => 10404
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/756/06756365.pdf
[firstpage_image] =>[orig_patent_app_number] => 09504697
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/504697 | Reducing tetracycline resistance in living cells | Feb 15, 2000 | Issued |
Array
(
[id] => 1566671
[patent_doc_number] => 06376479
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Method for treating and preventing hyperparathyroidism'
[patent_app_type] => B1
[patent_app_number] => 09/501093
[patent_app_country] => US
[patent_app_date] => 2000-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7844
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376479.pdf
[firstpage_image] =>[orig_patent_app_number] => 09501093
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/501093 | Method for treating and preventing hyperparathyroidism | Feb 8, 2000 | Issued |
Array
(
[id] => 4383148
[patent_doc_number] => 06294550
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-25
[patent_title] => 'Treatment of female sexual dysfunction'
[patent_app_type] => 1
[patent_app_number] => 9/501098
[patent_app_country] => US
[patent_app_date] => 2000-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9359
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/294/06294550.pdf
[firstpage_image] =>[orig_patent_app_number] => 501098
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/501098 | Treatment of female sexual dysfunction | Feb 8, 2000 | Issued |
Array
(
[id] => 1575239
[patent_doc_number] => 06469016
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Treatment of female sexual dysfunction using phosphodiesterase inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/499959
[patent_app_country] => US
[patent_app_date] => 2000-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10232
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469016.pdf
[firstpage_image] =>[orig_patent_app_number] => 09499959
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/499959 | Treatment of female sexual dysfunction using phosphodiesterase inhibitors | Feb 7, 2000 | Issued |